(Q45854225)

16 December 2017

title

Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies (English)

1 reference

16 December 2017

1 reference

5

Broliden K

1 reference

16 December 2017

8

Norrby E

1 reference

16 December 2017

author name string

Broliden PA

1

1 reference

16 December 2017

Mäkitalo B

2

1 reference

16 December 2017

Akerblom L

3

1 reference

16 December 2017

Rosen J

4

1 reference

16 December 2017

Utter G

6

1 reference

16 December 2017

Jondal M

7

1 reference

16 December 2017

Wahren B

9

1 reference

16 December 2017

publication date

1 August 1991

1 reference

16 December 2017

published in

Immunology

1 reference

16 December 2017

volume

73

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

371-376

1 reference

16 December 2017

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

cites work

1 reference

12 December 2020

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

12 December 2020

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

1 reference

12 December 2020

Superinfection of a chimpanzee with a second strain of human immunodeficiency virus

1 reference

12 December 2020

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis

1 reference

12 December 2020

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

1 reference

12 December 2020

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

1 reference

12 December 2020

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

1 reference

12 December 2020

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

1 reference

12 December 2020

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

12 December 2020

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Natural immunity to HIV and its possible relationship to vaccine strategies

1 reference

12 December 2020

Characterization of HIV-1 neutralization escape mutants

1 reference

12 December 2020

Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.

1 reference

12 December 2020

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

1 reference

12 December 2020

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

1 reference

12 December 2020

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

12 December 2020

Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping

1 reference

12 December 2020

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

1 reference

12 December 2020

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

12 December 2020

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

12 December 2020

Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.

1 reference

12 December 2020

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

1 reference

12 December 2020

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

1 reference

12 December 2020

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

12 December 2020

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

12 December 2020

Vaccine protection against simian immunodeficiency virus infection

1 reference

12 December 2020

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1 reference

12 December 2020

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

1 reference

12 December 2020

Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS.

1 reference

12 December 2020

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

1 reference

12 December 2020

Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages

1 reference

12 December 2020

Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.

1 reference

12 December 2020

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

12 December 2020

Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.

1 reference

12 December 2020

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

1 reference

12 December 2020

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

12 December 2020

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

1 reference

12 December 2020

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV

1 reference

12 December 2020

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

1 reference

12 December 2020

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

1 reference

12 December 2020

Identifiers

PubMed ID

1916888

1 reference

16 December 2017